{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:31:53Z","timestamp":1764174713695,"version":"3.40.5"},"reference-count":41,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.20197938","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T19:34:08Z","timestamp":1564256048000},"page":"313-319","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives"],"prefix":"10.1590","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2874-6771","authenticated-orcid":false,"given":"Luiz","family":"Gameiro","sequence":"first","affiliation":[{"name":"Faculdade de Medicina de Jundia\u00ed, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5327-883X","authenticated-orcid":false,"given":"Luis Fernando Requejo","family":"Tovo","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Jundia\u00ed, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-092X","authenticated-orcid":false,"given":"Jos\u00e9 Antonio","family":"Sanches J\u00fanior","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-7895","authenticated-orcid":false,"given":"Ivan","family":"Aprahamian","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Jundia\u00ed, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2019,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1040-8428(01)00185-8","article-title":"Chemoprevention of human skin cancer","volume":"41","author":"Einspahr JG","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl 2","key":"ref2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.2007.08268.x","article-title":"Management of field change in actinic keratosis","volume":"157","author":"Vatve M","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref3","first-page":"425","article-title":"Queratoses act\u00ednicas: revis\u00e3o cl\u00ednica e epidemiol\u00f3gica","volume":"87","author":"Schmitt JV","year":"2012","journal-title":"An Bras Dermatol"},{"key":"ref4","article-title":"Top dermatologic diagnoses by age","volume":"20","author":"Landis ET","year":"2014","journal-title":"Dermatol Online J"},{"key":"ref5","first-page":"549","article-title":"Nosologic profile of dermatologic visits in Brazil","volume":"81","year":"2006","journal-title":"An Bras Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.1994.tb08544.x","article-title":"Epidemiology of solar keratoses","volume":"131","author":"Frost CA","year":"1994","journal-title":"Br J Dermatol"},{"key":"ref7","first-page":"154","article-title":"Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results","volume":"13","author":"Berman B","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1590\/S0102-311X2009000500003","article-title":"Prevalence of precancerous skin lesions and non-melanoma skin cancer in Japanese-Brazilians in Bauru, S\u00e3o Paulo State, Brazil","volume":"25","author":"Ishioka P","year":"2009","journal-title":"Cad Saude Publica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CCID.S28905","article-title":"New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel","volume":"5","author":"Berman B","year":"2012","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1517\/14740338.2015.1108962","article-title":"Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis","volume":"14","author":"Berman B","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic Keratoses. Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione VD","year":"2009","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archderm.1991.01680060103013","article-title":"Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective","volume":"127","author":"Dodson JM","year":"1991","journal-title":"Arch Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks R","year":"1988","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.15107","article-title":"British Association of Dermatologists\u2019 guidelines for the care of patients with actinic keratosis 2017","volume":"176","author":"de Berker D","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1684\/ejd.2014.2368","article-title":"The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP)","volume":"24","author":"Tzogani K","year":"2014","journal-title":"Eur J Dermatol"},{"key":"ref16","first-page":"310","article-title":"Field cancerization: a review article","volume":"6","author":"Abdalla B","year":"2014","journal-title":"Surg Cosmet Dermatol"},{"key":"ref17","first-page":"1462","article-title":"The paradigm shift in treating actinic keratosis: A comprehensive strategy","volume":"11","author":"Stockfleth E","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"ref18","first-page":"775","article-title":"Campo de canceriza\u00e7\u00e3o cut\u00e2neo: implica\u00e7\u00f5es cl\u00ednicas, histopatol\u00f3gicas e terap\u00eauticas","volume":"88","author":"Torezan LA","year":"2013","journal-title":"An Bras Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/jdv.13180","article-title":"Evidence-and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version","volume":"29","author":"Werner RN","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jdv.13648","article-title":"Italian expert consensus for the management of actinic keratosis in immunocompetent patients","volume":"30","author":"Peris K","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","article-title":"Swiss clinical practice guidelines on field cancerization of the skin","volume":"144","author":"Hofbauer G","year":"2014","journal-title":"Swiss Med Wkly"},{"series-title":"Consulta de produtos\/ medicamentos","key":"ref22"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: Rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"Rosen RH","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"Ogbourne SM","year":"2004","journal-title":"Cancer Res"},{"key":"ref25","first-page":"1181","article-title":"Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells","volume":"11","author":"Stahlhut M","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00262-008-0458-9","article-title":"The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner","volume":"57","author":"Hampson P","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl M","year":"2012","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2013.2766","article-title":"Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses","volume":"149","author":"Lebwohl M","year":"2013","journal-title":"JAMA Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.14222","article-title":"Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0\u00b7015% gel: a randomized, controlled 12-month study","volume":"174","author":"Garbe C","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jdv.13063","article-title":"Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial","volume":"29","author":"Samorano LP","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"series-title":"Product information","key":"ref31"},{"issue":"Suppl 1","key":"ref32","article-title":"Safety of follow-up field application of ingenol mebutate 0.015% gel for actinic keratoses on face and scalp","volume":"72","author":"Garbe C","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/jdv.13211","article-title":"A randomized trial comparing simultaneous versus sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body","volume":"29","author":"Pellacani G","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/DSS.0000000000000503","article-title":"Cosmetic effects of ingenol mebutate gel in the treatment of field-cancerized photodamaged skin","volume":"41","author":"Braun SA","year":"2015","journal-title":"Dermatol Surg"},{"key":"ref35","first-page":"19","article-title":"Tolerability and pharmacokinetics of ingenol mebutate 0.05% gel applied to treatment areas up to 100 cm2 on the forearm(s) of patients with actinic keratosis","volume":"7","author":"Anderson L","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"series-title":"PICATO\u00aegel. Bula aprovada pela ANVISA (09\/06\/2015)","key":"ref36"},{"key":"ref37","first-page":"35","article-title":"Non-adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill B","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jval.2013.03.1631","article-title":"Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group","volume":"16","author":"Gwadry-Sridhar FH","year":"2013","journal-title":"Value Health"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman RE","year":"2016","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/09546634.2016.1161162","article-title":"Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study","volume":"27","author":"Ricci F","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ijd.12840","article-title":"A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis","volume":"54","author":"Stockfleth E","year":"2015","journal-title":"Int J Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v94n3\/0365-0596-abd-94-03-0313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:46Z","timestamp":1747666846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962019000300313&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["S0365-05962019000300313"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20197938","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"type":"electronic","value":"1806-4841"},{"type":"print","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}